Company / R&D Expense
Evolus, Inc. R&D Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$6.6M
FY2025
5-year range
$1.7M / $6.6M
FY2021-FY2025
Trend
+38.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $5M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2025 with a 5-year CAGR of +10.5%.
Improved from $5M to $7M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +47.0%
- 5-Year CAGR
- +10.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +10.5%, indicating consistent growth.
- In FY2025, r&d expense increased 38.3% year-over-year.
- Lowest r&d expense in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.6M | +38.3% |
| FY2024 | $4.7M | +0.0% |
| FY2023 | $4.7M | +129.7% |
| FY2022 | $2.1M | +19.9% |
| FY2021 | $1.7M | -56.7% |
| FY2020 | $4.0M | -38.8% |
| FY2019 | $6.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026